Showing results (31-40 of 147) with videos related to

Sort By:
Pageof 15
Multiple Sclerosis and Related Disorders|April 12, 2016
Bone health in patients with multiple sclerosis relapsesOlwen Murphy, Michael S Zandi, Nitzan Lindenberg, et al.
Disability and Rehabilitation|September 30, 2016
The experience of transitioning from relapsing remitting to secondary progressive multiple sclerosis: views of patients and health professionalsEmer O'Loughlin, Susan Hourihan, Jeremy Chataway, et al.
Current Medical Research and Opinion|March 18, 2021
Secondary progressive multiple sclerosis: a systematic review of costs and health state utilitiesJeremy Chataway, Niamh Murphy, Vivek Khurana, et al.
Health and Quality of Life Outcomes|September 28, 2011
A tool to measure the attributes of receiving IV therapy in a home versus hospital setting: the Multiple Sclerosis Relapse Management Scale (MSRMS)Afsane Riazi, Bernadette Porter, Jeremy Chataway, et al.
Archives of Neurology|February 14, 2007
Adult-onset neurodegeneration with brain iron accumulation and cortical alpha-synuclein and tau pathology: a distinct clinicopathological entityGeorge K Tofaris, Tamas Revesz, Thomas S Jacques, et al.
Neurology|February 23, 2018
Effects of ATX-MS-1467 immunotherapy over 16 weeks in relapsing multiple sclerosisJeremy Chataway, Keith Martin, Kevin Barrell, et al.
The Lancet. Neurology|June 20, 2006
Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trialJeremy Chataway, Bernadette Porter, Afsane Riazi, et al.
The Lancet. Neurology|February 16, 2024
Clinical trials for progressive multiple sclerosis: progress, new lessons learned, and remaining challengesJeremy Chataway, Thomas Williams, Vivien Li, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 4, 2020
Measuring the cost-effectiveness of treatments for people with multiple sclerosis: Beyond quality-adjusted life-yearsAnnie Hawton, Elizabeth Goodwin, Kate Boddy, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 12, 2026
Recalibration and external validation of vascular risk calculators for multiple sclerosis: A population-based study using CPRD data in England, 1987-2023Raffaele Palladino, Ruth Ann Marrie, Giuseppina Affinito, et al.
Pageof 15